6-K
Eupraxia Pharmaceuticals Inc. (EPRX)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2026
Commission File Number: 001-41923
Eupraxia Pharmaceuticals Inc.
(Translation of registrant’s name into English)
201-2067 Cadboro Bay Road
Victoria, British Columbia, Canada V8R 5G4
Telephone : (250) 590-3968
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐ Form 40-F ☒
DOCUMENTS INCLUDED AS PART OF THIS REPORT
| Exhibit | |
|---|---|
| 99.1 | Notice of Record and Meeting Date |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Eupraxia Pharmaceuticals Inc.. | |
|---|---|
| (Registrant) | |
| Date: April 14, 2026 | /s/ Alex Rothwell |
| Alex Rothwell | |
| Chief Financial Officer |
EX-99.1
Exhibit 99.1
TSX TRUST COMPANY
VIA ELECTRONIC TRANSMISSION
April 13, 2026
TO ALL APPLICABLE EXCHANGES AND COMMISSIONS:
| RE: | EUPRAXIA PHARMACEUTICALS INC. |
|---|
Confirmation of Notice of Record and Meeting Dates
We are pleased to confirm that the Notice of Record and Meeting Dates was sent to The Canadian Depository for Securities.
We advise the following with respect to the upcoming Annual General Meeting of Security Holders for the subject issuer:
| 1 | ISIN: | CA29842P1053 |
|---|---|---|
| CUSIP: | 29842P105 | |
| 2 | Date Fixed for the Meeting: | June 18, 2026 |
| 3 | Record Date for Notice: | May 8, 2026 |
| 4 | Record Date for Voting: | May 8, 2026 |
| 5 | Beneficial Ownership Determination Date: | May 8, 2026 |
| 6 | Classes or Series of Securities that entitle the holder to receive Notice of the Meeting: | COMMON SHARES |
| 7 | Classes or Series of Securities that entitle the holder to vote at the meeting: | COMMON SHARES |
| 8 | Business to be conducted at the meeting: | Annual General |
| 9 | Notice-and-Access: | |
| Registered Shareholders: | NO | |
| Beneficial Holders: | NO | |
| Stratification Level: | Not Applicable | |
| 10 | Reporting issuer is sending proxy-related materials directly to Non-Objecting Beneficial Owners: | NO |
| 11 | Issuer paying for delivery to Objecting Beneficial Owners: | NO |
Yours truly,
TSX TrustCompany
| VANCOUVER | CALGARY | TORONTO | MONTRÉAL |
|---|---|---|---|
| 733 Seymour Street, | Telus Sky Building | 301 - 100 Adelaide Street West | 1701 - 1190, avenue des |
| Suite #2310 | 2110, 685 Centre Street SW | Toronto ON M5H 4H1 | Canadiens-de-Montréal, C. P. 37 |
| Vancouver, BC V6B 0S6 | Calgary Alberta T2G 1S5 | Montréal (Québec) H3B 0G7 | |
| Toll Free 1-866-600-5869 | |||
| T 604 689-3334 | T 403 218-2800 | T 416 361-0930 | T 514 395-5964 |